Steroid Refractory GVHD (DBCOND0054987)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT04769895	MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients	MaaT013	treatment	3	active_not_recruiting
NCT04768907	Early Access Program With MaaT013 in Steroid-refractory Acute Gastrointestinal Graft Versus Host Disease	MaaT013	Not Available	Not Available	available
NCT05052385	ECP Combination Study	Ibrutinib Ruxolitinib	Not Available	Not Available	completed
NCT05663827	Ruxolitinib as add-on Therapy in Steroid-refractory Graft-vs-host Disease	Ruxolitinib	treatment	3	completed
NCT06343792	Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute Graft-versus-Host Disease	No drug interventions	treatment	2	recruiting
NCT04070781	Itacitinib and Tocilizumab for Steroid Refractory Acute Graft Versus Host Disease	Itacitinib Tocilizumab	treatment	1	terminated
NCT04289103	Evaluation of EFficacy and SaFEty of Leukotac (Inolimomab) in Pediatric Patients With SR-aGvHD	Inolimomab	treatment	3	unknown_status
NCT05017688	Prospective Interventional Study Exploring the Microbiota Recolonization in SR-GvHD Patients Receiving MaaT013	No drug interventions	other	Not Available	recruiting
NCT04926194	Decidual Stromal Cells to Treat Graft-vs-Host Disease After Stem Cell Transplant for Myelodysplastic Syndrome/Myeloproliferative Neoplasm	No drug interventions	treatment	2	completed
NCT01485055	Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease	Basiliximab Infliximab	treatment	2	terminated